GROUPAMA ASSET MANAGMENT

Position in DNLI — Denali Therapeutics Inc.

CIK 1055969 PARIS, I0

Position in DNLI

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$3,976,896

+$1,474,129 QoQ

Shares Held

207,130

+36.6% QoQ

Ownership

0.131%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $249,620,066 across 10 Biotechnology names. DNLI ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	165,897	$74,079,646
2	IONS	Ionis Pharmaceuticals Inc	824,540	$61,914,708
3	REGN	Regeneron Pharmaceuticals, Inc.	71,102	$54,936,249
4	MDGL	Madrigal Pharmaceuticals, Inc.	35,238	$18,446,035
5	BNTX	BioNTech SE	185,036	$16,445,999
6	ALNY	Alnylam Pharmaceuticals, Inc.	36,767	$12,165,097
7	INCY	Incyte Corp	66,451	$6,254,368
8	DNLI	Denali Therapeutics Inc. This page	207,130	$3,976,896

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,976,896	207,130	+36.6%	Shares	Sole	2026-05-22
2025-12-31	$2,502,767	151,591	+11.7%	Shares	Sole	2026-02-27
2025-09-30	$1,971,206	135,758	-22.7%	Shares	Sole	2025-12-01
2025-06-30	$2,455,678	175,531	+21.5%	Shares	Sole	2025-08-13
2025-03-31	$1,964,314	144,488	+31.1%	Shares	Sole	2025-05-14
2024-12-31	$2,246,018	110,207	+41.2%	Shares	Sole	2025-02-12
2024-09-30	$2,273,450	78,045	+7.8%	Shares	Sole	2024-11-15
2024-06-30	$1,680,849	72,388	+65.2%	Shares	Sole	2024-08-14
2024-03-31	$899,330	43,827	+25.2%	Shares	Sole	2024-05-14
2023-12-31	$751,378	35,013	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.